Clinical Trials

LymphoidMyeloidOther hematologic neoplasm

7 enrolled 12 charts

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01753453 2021-02-23

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

23 enrolled

Plasma cell

Multiple Myeloma

NCT02200380 2017-04-07

A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs

LymphoidMyeloidOther hematologic neoplasm

36 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02221492 2016-03-30

Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma

32 enrolled

Lymphoid

Lymphoma

NCT02221479 2015-08-04

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

14 enrolled

Plasma cell

Multiple Myeloma

NCT00395967 2015-05-01

AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone

5 enrolled 8 charts

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00322387 2014-03-13

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

40 enrolled 10 charts

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00322491 2014-03-13

Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

49 enrolled 13 charts

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00322842 2014-03-13

Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

35 enrolled 13 charts

Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00396201 2014-03-13

AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease

22 enrolled 17 charts

Lymphoid

Hodgkin Disease

NCT00396383 2014-03-13

Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation

9 enrolled 8 charts

Plasma cell

Multiple Myeloma

NCT00665314 2014-02-11

Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).

5 enrolled